A genome wide association analysis in the GENDER study

Netherlands Heart Journal

Volumn 17, Issue 6, 2009, Pages 262-264

  Sampietro, M L ^a,b,c   Pons, D ^a,b,c   De Knijff, P ^a   Slagboom, P E ^a   Zwinderman, A H ^d   Jukema, J W ^a,b,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Durrer Center for Cardiogenetic Research   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Genome wide association scan; Percutaneous coronary intervention; Restenosis; SNP

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME ANALYSIS; GENOME WIDE ASSOCIATION SCAN; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 70349272478     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03086261     Document Type: Article

References (21)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-1504
2. Moses JW, Kipshidze N, Leon MB. Perspectives of drug-eluting stents: the next revolution. Am J Cardiovasc Drugs 2002;2:163-172 (Pubitemid 34830657)
3. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-706 (Pubitemid 17036474)
4. Lee MS, David EM, Makkar RR, Wilentz JR. Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system. J Pathol 2004;203:861-870
5. Agema WR, Monraats PS, Zwinderman AH, de Winter RJ, Tio RA, Doevendans PA, et al. Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era. Eur Heart J 2004;25:1163-1170
6. Pache J, Kastrati A, Mehilli J, Schuhlen H, Dotzer F, Hausleiter J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 2003;41:1283-1288 (Pubitemid 36438988)
7. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12:616-623 (Pubitemid 18203717)
8. Bourassa MG, Lesperance J, Eastwood C, Schwartz L, Cote G, Kazim F, et al. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1991;18:368-376
9. Sobel BE. Acceleration of restenosis by diabetes: pathogenetic implications. Circulation 2001;103:1185-1187
10. Kastrati A, Schomig A, Elezi S, Schuhlen H, Wilhelm M, Dirschinger J. Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions. Circulation 1998;97:2396-2401 (Pubitemid 28278182)
11. Monraats PS, Agema RP, Jukema JW. Genetic predictive factors in restenosis. Pathol Biol (Paris) 2004;52:186-195
12. Monraats PS, Pires NM, Schepers A, Agema WR, Boesten LS, De Vries MR, et al. Tumor necrosis factor-alpha plays an important role in restenosis development. FASEB J 2005;19:1998-2004. (Pubitemid 41759745)
13. Monraats PS, Pires NM, Agema WR, Zwinderman AH, Schepers A, de Maat MP, et al. Genetic inflammatory factors predict restenosis after percutaneous coronary interventions. Circulation 2005;112:2417-2425 (Pubitemid 41504491)
14. Monraats PS, Rana JS, Nierman MC, Pires NM, Zwinderman AH, Kastelein JJ, et al. Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention. J Am Coll Cardiol 2005;46:1093-1100 (Pubitemid 41316520)
15. Monraats PS, Rana JS, Zwinderman AH, de Maat MP, Kastelein JP, Agema WR, et al. -455G/A polymorphism and preprocedural plasma levels of fibrinogen show no association with the risk of clinical restenosis in patients with coronary stent placement. Thromb Haemost 2005;93:564-569
16. Monraats PS, de Vries F, de Jong LW, Pons D, Sewgobind VD, Zwinderman AH, et al. Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention. Pharmacogenet Genomics 2006;16:747-754 (Pubitemid 44454869)
17. Monraats PS, Kurreeman FA, Pons D, Sewgobind VD, de Vries FR, Zwinderman AH, et al. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention. Genes Immun 2007;8:44-50. (Pubitemid 46158102)
18. Scherer SW, Lee C, Birney E, Altshuler DM, Eichler EE, Carter NP, et al. Challenges and standards in integrating surveys of structural variation. Nat Genet 2007;39(7 Suppl):S7-15. (Pubitemid 47014477)
19. de Cid R, Riveira-Munoz E, Zeeuwen PL, Robarge J, Liao W, Dannhauser EN, et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 2009;41:211-215
20. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008;82:477-488
21. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008;455:232-236